click below
click below
Normal Size Small Size show me how
antimicrobial test1
Question | Answer |
---|---|
Penicillinase resistant | Dicloxacillin |
PCNase resistant | Nafcillin |
PCNase resistant | Oxacillin |
PCNase resistant | Methicillin |
Anti-pseudo PCN | carboxyPCNs |
CarboxyPCNs | Ticarcillin, Carbenecillin |
Anti-pseudo PCN | ticarcillin |
Anti-pseduo PCN | carbenecillin |
Anti-pseudo PCN | UreidoPCN |
UreidoPCN | piperacillin, mexlocillin |
Anti-pseudo PCN | piperacillin |
Anti-pseudo PCN | mexlocillin |
Augmentin | Ampicillin & clavulonic acid |
Zosyn | Piperacillin & taxobactam |
2nd gen Cephs | Cefaclor, Cefotoxin, Loracarbef |
3rd gen Cephs | Ceftriaxone, Ceftazidime, Cefixime |
4th gen Ceph | Cefepime |
5th gen Ceph | Ceftaroline |
Imipenem | combined w/cilastin |
50s | Chloramphenicol |
50S | clindamycin |
50s | linezolid |
50s | macrolides |
50s | quinupristin |
50s | dalfopristin |
macrolide | erthromycin |
macrolide | azithromycin |
macrolide | clarithromycin |
30s | tetracycline |
30s | tigecycline |
30s | spectinomycin |
30s | aminoglycosides |
aminoglycoside | streptomycin |
aminoglycoside | gentamycin |
aminoglycoside | tobramycin |
aminoglycoside | amikacin |
aminoglycoside | neomycin |
fluroquinolones | naladixic acid |
fluroquinolones | 'floxins' - Ciprofloxin, Levofloxin, Trovafloxacin |
Lipoglycopeptide | dalbavancin |
lipoglycopeptide | telavancin |
cyclic lipopeptide | daptomycin |
tefibazumab | staph antibody |
anti-Tb | Isoniazid |
anti-TB | rifampin |
anti-TB | pyrazinamide |
anti-TB | ethambutol |
anti-TB | rifabutin |
anti-TB | streptomycin |
Rifapentine | latent TB |
isoniazid | latent TB |
mixed amebicide | metronidazole |
mixed amebicide | tinadazole |
anti-leprosy | sulfones (dapson/sulfoxone) |
anti-leprosy | rifampin |
MOA PCNs | inhibit transpeptidases, bind PCN-binding proteins, alter configuration of PG layer |
PCN drug of choice for | GAS, GBS, T.pallidum |
Natural PCN | broad spectrum |
Aminopencillins | better Gm-; Gm+ enterococci increasing resistance |
causes interstitial nephritis | Methicillin |
increases Na overload, platelet dysfunction, hypokalemia | carbenecillin |
Beta Lactamase inhibitors | clavulonic acid, sulbactam, taxobactam |
uses for beta lactamase inhibitors | hosp acquired pneumo, anaerobes |
used for MRSA | vancomycin |
not absorbed in GI so good for Cdiff | vancomycin |
CNS penetration | vancomycin |
causes red man syndrome when used IV | vancomycin |
red man syndrome | nonimmunologic histamine release |
MOA vancomycin | inhibits prostaglandin biosynthesis a step earlier than PCN and inhibits transpeptidases |
uses of vancomycin | ALL G+ |
MOA cephalosporins | competitive inhibitor of transpeptidase |
PCNs | cidal |
cephalosporins | cidal |
vancomycin | cidal |
monobactams | cidal |
carbapenems | cidal |
1st generation Ceph is more blank than blank | more Gm+ than Gm- |
3rd generation ceph is more blank than blank | more Gm- than Gm+ |
adverse effect of interfering with Vit K dependant clotting | 2nd gen ceph (cefaclor, cefoxitin, Loracarbef) |
might be good for pseudomonas | 3rd gen ceph |
good CNS penetration | 3rd gen ceph |
tx meningitis | 3rd gen cep |
tx meningitis | vancomycin |
Cefepime | good Gm+ & Gm- coverage |
nosocomial pneumonias (pseudomonas) | cefepime |
empiric tx for febrile neutropenia | cefepime |
ceftaroline | good for community acquired pneumonia |
good for MRSA | ceftaroline |
1st ceph w/activity against MRSA | ceftaroline |
1st drug for CAP since 1998 | ceftaroline |
broad spectrum & highly resistant to B lactamases | carbapenems |
combined with cilastin | imipenem |
cilastin | inhibits kidney enzyme that metabolizes the drug its combined with and protects from toxicity |
good for MRSA | ertapenem |
good for ESBL organisms | ertapenem |
only Gm- | monobactams |
used to tx septicemia | monobactams |
single B lactam ring not fused with another | aztreonam |
all 50s static except for | quinupristin/dalfopristin |
chloramphenicol causes | bone marrow depression w/aplastic anemia |
chloramphenicol causes | grey baby syndrome |
used in Rickettsia | chloramphenicol |
used in meningtitis when allergic to PCN, ceph | chloramphenicol |
side effect of clindamycin | pseudomembranous c.diff |
used when allergic to PCN & ceph | clindamycin |
MOA clindamycin | inhibits toxin production by blocking protein synthesis |
used in strep pyogenes & staph TSS | clindamycin |
Gm+ | clindamycin |
side effects of linezolid | bone marrow suppression (thrombocytopenia, anemia & leukopenia) |
mostly Gm+ | linezolid |
used for HAP, CAP, staph, MRSA, VRE | linezolid |
metabolized cyp450 | macrolides |
metabolized cyp450 | erythromyc & clarithromycin |
causes QT prolongation | macrolides |
interaction with anti-epileptics, warfarin, birth control | macrolides |
have anti-inflammatory properties | macrolides |
inhibit mononuclear cells, reduce superoxide by PMNs, modify release of cytokines, inhibit biofilms | macrolides |
binds to 2 separate sites on protein - irreversible | quinupristin/dalfopristin |
multi-drug resistant Gm+ cocci | quinupristin/dalfopristin |
VRE | static quinupristin/dalfopristin |
MSSA, MRSA, S.pyogenes | cidal quinupristin/dalfopristin |
metabolized cyp450 | quinupristin/dalfopristin |
side effects of quinupristin/dalfopristin | venous irritation |
30s | all static |
tetracycline | also includes doxycycline |
take this 1 hr before or 3hrs after eating | tetracycline |
causes photosensitivity, teeth discoloration | tetracycline |
monocycline side effects | lupus like reaction, vertigo, arthritis |
tigecycline | slow IV infusion |
used for MRSA, VRE, ESBL, MDR acinetobacter | tigecycline |
NO activity against pseudomonas | tigecycline |
spectinomycin | aminocyclitol abx, closely related to aminoglycosides |
often used with PCN to facilitate crossing bacterial Cell wall | aminoglycosides |
crosses CNS only with meningeal inflammation | aminoglycosides |
oldest aminoglycoside | streptomycin |
M/C used aminoglycoside | gentamycin |
aminoglycoside used for pseudomonas | tobramycin |
aminoglycoside with broadest spectrum | amikacin |
topical, toxic aminoglycoside | neomycin |
aminoglycoside side effects | vestibular, auditory & nephrotoxicity; neuromuscular blockade |
Gm- enteric, Tularemia, tersinia pestis | aminoglycosides |
Cidal | fluroquinolones |
safe high blood levels with oral absorption and good tissue penetration | fluroquinolones |
MOA fluorquinolones | inhibit DNA gyrase |
good Gm- coverage | fluroquinolones |
resistance is developind due to mutation in bacterial DNA | fluroquinolones |
Naladixic acid | 1st generation fluroquinolones |
side effect fluoroquinilones | tendon rupture & tendinitis |
causes c.diff | fluroquinolones |
side effects of ciprofloxin | inhibits GABA- and causes seizures in pt with renal insufficiency |
used for chronic bone infxns | fluroquinolones |
moxofloxacin | empiric coverage intra-ab infxn & broad spectrum & anaerobes |
novel second generation lipoglycopeptide that belongs to same class as Vancomycin | dalbavancin |
not yet FDA approved | dalbavancin |
for hospital pt with difficult to tx MRSA | dalbavancin |
telavancin | also a lipoglycopeptide |
MOA telavancin | dual action - inhibits cell wall synthesis & dissipates cell membrane potential |
qualified infectious disease product | used @ instutions with a specialist - telavancin |
tefibazumab | monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A |
daptomycin | newer class of cyclic lipopeptide |
causes rapid depolarization Gm+ cell membrane potential inhibiting bacterial DNA, RNA & protein synthesis | daptomycin |
side effect of daptomycin | constipation |
potential for myopathy | daptomycin |
monitor CPK when on this | daptomycin |
broad Gm+ coverage of org resistant to methicillin & vancomycin | daptomycin |
used in complicated skin & soft tissue infxn: MRSA, VRE, s.agalactiae | daptomycin |
isoniazid MOA | interferes with biosyn of mycolic acid component of cell wall |
isoniazid side effects | hepatotoxicity |
can induce pyridoxine deficiency (Vit B6), causing pellagra manifested by peripheral neuritis, rash & anemia | isoniazid |
rifampin MOA | inhibits DNA-dependent RNA polymerase |
rifampin side effects | jaundice, red/orange sweat, urine, tears |
used for TB & leprosy | rifampin |
prophylaxis for exposure to N. meningitides | rifampin |
induces p450 | rifampin |
pyrazinamide | causes hepatotoxic, gout |
ethambutol | crosses BBB |
visual disturbance side effects | ethambutol |
only 1st line TB that is bacterostatic | ethambutol |
rifabutin MOA | inhibits DNA-dependent RNA polymerase |
side effects rifabutin | uveitis, orange urine, sweat, tears |
used in combo for prevention & tx M. avium or M. intracellulare | rifabutin |
increases drug interactions with heart therapy | rifapentine & inh (drugs for latent TB) |
take for 3 months | rifapentine & INH |
take for 9 months | INH only |
sulfonamides MOA | competitive inhibition DHPS which converts PABA in folate synthesis (important for DNA synthesis) therfore bacteriostatic |
sulfonamides | no toxicity |
diuretics, sulfonlylureas & acetazolamide | sulfa moity also present so beware sulfa allergy |
sulfonamides side effects | steven-johnson syndrome, severe sun burn |
used to treat UTIs, otitis media, sinusitis, bronchitis, MRSA | sulfonamides |
topical silver sulfadiazine | tx burns |
sulfadiazine | protect ppl w/RF from infx; tx toxoplasmosis |
sulfasalazine | anti-inflammatory agent |
metronidazole MOA | binds proteins & DNA - cell death |
severe GI side effects | metronidazole |
severe CNS depression in elderly side effects | metronidazole |
drug of choice for psudomembranous colitis caused by Gm+ cdiff | metronidazole |
tinidazole | shorter course of tx than the other amebicide |
Leprosy | hansens disease |
lepromatous leprosy | low cell-mediated immunity |
lepromatous leprosy | organisms everywhere, skin, nevers, eyes, testes |
lepromatous leprosy | leonine facies, saddle nose, peripheral neuropathy, digit absorption, blindness, infertility in men |
tuberculoid leprosy | intact cell-mediated immunity |
tuberculoid leprosy | difficult to isolate from skin or blood |
tuberculoid leprosy | skin & nerves involved (1-2 superficial unilateral lesions) |
most common cause of neuropathy worldwide | leprosy |
Daptomycin | no activity against Gm- |
becomes inactivated by pulmonary surfactant therefore not appropriate for pneumonia | daptomycin |
methods to figure out MIC | dilution method & disc diffusion method |
Bacteriocidal | have MBC similar to MIC |
bacteriostatic | have MBC higher than MIC |
stronger ABX | have very low MICs |
MIC of resistant org | >2 |
four pharmacokinetic processes | absorption, distribution, metabolism, excretion |
pharmacokinetics | how much of drug arrives at destination to have an effect |
pharmacokinetics | determines time course of drug response & appropriate dosing strategies |
pharmacodynamics | drug receptor interaction, pt functional status, placebo |
pharmacodynamics | determines the nature & intensity of the response |
pharmacodynamic/pharmacokinetic drug activity ration | PD/PK: takes into account the peak drug CONCENTRATION & length of TIME of drug exposure at site of infection - it is time/concentration!! |
who produces beta lactamase | H. flu, M.catarrhalis, anaerobic bacteria, gonorrhea also now |
B-lactamase production | binding is irreversible & cannot be overcome with higher dosing but CAN BE OVERCOME WITH B-LACTAMASE INHIBITORS |